Table 5.
AJCC Stage |
Group | P-value vs. <12 nodes |
---|---|---|
1 | <=40 - 12+nodes | .564 |
41–45 12+ nodes | .232 | |
46–50 - 12+ nodes | .871 | |
51–55 - 12+ nodes | .911 | |
56–60 - 12+ nodes | .939 | |
61–65 - 12+ nodes | .258 | |
66–70 - 12+ nodes | .568 | |
71–75 - 12+ nodes | .097 | |
76–80 - 12+ nodes | .503 | |
81–85 - 12+ nodes | .088 | |
86+ - 12+ nodes | .687 | |
2 | <=40 - 12+nodes | .000 |
41–45 12+ nodes | .050 | |
46–50 - 12+ nodes | .000 | |
51–55 - 12+ nodes | .000 | |
56–60 - 12+ nodes | .001 | |
61–65 - 12+ nodes | .000 | |
66–70 - 12+ nodes | .000 | |
71–75 - 12+ nodes | .000 | |
76–80 - 12+ nodes | .000 | |
81–85 - 12+ nodes | .000 | |
86+ - 12+ nodes | .000 | |
3 | <=40 - 12+nodes | .073 |
41–45 12+ nodes | .129 | |
46–50 - 12+ nodes | .348 | |
51–55 - 12+ nodes | .249 | |
56–60 - 12+ nodes | .673 | |
61–65 - 12+ nodes | .033 | |
66–70 - 12+ nodes | .317 | |
71–75 - 12+ nodes | .062 | |
76–80 - 12+ nodes | .023 | |
81–85 - 12+ nodes | .004 | |
86+ - 12+ nodes | .041 |
AJCC: American Joint Committee on Cancer